Alzheimers
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Early Detection of Alzheimer's Disease Using Explainable Machine Learning on Clinical Biomarkers: A Multi-Class Classification Study Using the Alzheimer's Disease Neuroimaging Initiative (ADNI) Dataset
Announce Type: new Abstract: Background: Alzheimer's disease (AD) affects over 55 million people worldwide. Accurate, interpretable detection of normal cognition (NC), mild cognitive impairment (MCI), and AD from routine clinical assessments remains a critical unmet need. Methods: An XGBoost classifier was developed for three-class detection using eight clinical features from the Alzheimer's Disease Neuroimaging Initiative (ADNI): MMSE, CDR Global, CDR Sum of Boxes (CDR-SB), MoCA, FAQ, age,...
Huge study of Alzheimer’s genetics identifies new drug targets
The biggest genetic study of Alzheimer’s disease so far has identified 127 gene locations that are associated with the condition, of which 48 are new. The study also pinpoints several genes that could be prioritised as drug targets and cell types linked to a higher genetic risk of the condition. “It’s an exciting time for Alzheimer’s genetics,” says Rudolph Tanzi at Massachusetts General Hospital, who provided evidence of the first Alzheimer’s-linked gene, APP, in 1987.
Scientists found the hidden switch fueling alzheimer’s brain inflammation
Scientists found the hidden switch fueling alzheimer’s brain inflammation Scientists may have found a hidden Alzheimer’s “inflammation switch”—and turning it off protected brain connections in early studies. - Date: - May 31, 2026 - Source: - Scripps Research Institute - Summary: - Scientists at Scripps Research have uncovered a molecular “switch” that appears to fuel the damaging brain inflammation seen in Alzheimer’s disease. They found that a protein called STING becomes chemically...
Scientists found a new Alzheimer’s trigger and a drug that stops it
Scientists found a new Alzheimer’s trigger and a drug that stops it - Date: - June 8, 2026 - Source: - ETH Zurich - Summary: - Researchers have identified a new Alzheimer’s target and created an experimental compound that blocks a damaging process inside brain cells. In mice, the treatment slowed nerve cell loss, reduced Alzheimer’s-related changes, and even appeared to promote healthier aging. - Share: A promising experimental compound developed by researchers at ETH Zurich could offer a...
NHS doctor shares how to decrease Alzheimer's Disease risk as Jon Snow diagnosed
NHS doctor shares how to decrease Alzheimer's Disease risk as Jon Snow diagnosed Alzheimer's disease is a progressive, neurodegenerative condition and there is currently no cure, though treatments are available that may help to temporarily alleviate symptoms It was announced yesterday (Friday June 5) that veteran Channel 4 News presenter Jon Snow has been diagnosed with Alzheimer's disease. The 79-year-old broadcaster, who fronted Channel 4 News for over 30 years before retiring in 2021,...
A blood test could flag Alzheimer’s risk early. But how reliable is it?
Scientists have developed a blood test that could spot signals of Alzheimer's disease at a much younger age. A simple blood test may soon help identify people at higher risk of Alzheimer’s disease years before they develop symptoms, according to a new study. Researchers at the University of California, San Francisco (UCSF) in the United States, found that certain Alzheimer’s-related proteins in the blood were linked to small differences in thinking and memory among middle-aged adults who did...
Early Alzheimer's signs 'often' include two changes — not memory loss
Early Alzheimer's signs 'often' include two changes — not memory loss In the early stages of Alzheimer's disease, the NHS says there are often signs to look out for - and these early dementia symptoms can appear before memory problems become noticeable In the earliest stages of Alzheimer's disease – the most common form of dementia – there are additional symptoms to look out for, beyond the well-known memory problems. It is worth understanding, however, how memory issues typically present in...
Former Channel 4 News presenter Jon Snow diagnosed with Alzheimer’s disease
Former Channel 4 News presenter Jon Snow diagnosed with Alzheimer’s disease Jon Snow is set to share his experience in a Channel 4 documentary - Bookmark - CommentsGo to comments Veteran broadcaster Jon Snow, a familiar face from Channel 4 News, has been diagnosed with Alzheimer’s disease, the most prevalent form of dementia, the Alzheimer’s Society has confirmed. The 78-year-old journalist is set to explore the realities of living with the condition in an upcoming documentary, Jon Snow: A...
Former Channel 4 News anchor Jon Snow diagnosed with Alzheimer’s
Long-serving presenter has been diagnosed with commonest form of dementia, says Alzheimer’s SocietyThe former Channel 4 News anchor Jon Snow has been diagnosed with Alzheimer’s disease, the most common form of dementia, the Alzheimer’s Society has said. More details soon … Continue reading...
Former Channel 4 News anchor Jon Snow diagnosed with Alzheimer’s
Long-serving presenter has been diagnosed with dementia, says Alzheimer’s SocietyFormer Channel 4 News anchor Jon Snow has been diagnosed with Alzheimer’s disease, the most common form of dementia, the Alzheimer’s Society has said. More details soon … Continue reading...